Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy

Nanomedicine

Volumn 2, Issue 5, 2007, Pages 681-693

  Huang, Xiaohua ^a   Jain, Prashant K ^a   El Sayed, Ivan H ^a   El Sayed, Mostafa A ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cancer diagnostics; Gold nanoparticles; Gold nanorods; Mie scattering; Plasmonic photothermal therapy; Surface enhanced Raman scattering; Two photon luminescence

Indexed keywords

ANTINEOPLASTIC AGENT; COLLOIDAL GOLD; CONTRAST MEDIUM; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; NANOPARTICLE; NANOROD; NANOSPHERE;

ANTIBODY LABELING; BIOMEDICINE; CANCER CELL; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; FLUORESCENCE ANALYSIS; HUMAN; HYPERTHERMIC THERAPY; ILLUMINATION; LIGHT ABSORPTION; LIGHT SCATTERING; MOLECULAR IMAGING; MOLECULAR INTERACTION; NANOMEDICINE; NEAR INFRARED SPECTROSCOPY; NEODYMIUM LASER; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSCILLATION; PARTICLE SIZE; PHOTOTHERAPY; PRIORITY JOURNAL; QUANTUM YIELD; RAMAN SPECTROMETRY; REVIEW; SURFACE PLASMON RESONANCE;

DRUG DELIVERY SYSTEMS; GOLD; HUMANS; NANOMEDICINE; NANOPARTICLES; NEOPLASMS;

EID: 37249089714     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/17435889.2.5.681     Document Type: Review

References (171)

1. Bruchez Jr M, Moronne M, Gin F, Weiss S, Alivisatos AP: Semiconductor nanocrystals as fluorescent biological labels. Science 281 (5385), 2013-2016 (1998).
2. Chan WCW, Nie S: Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281(5385), 2016-2018 (1998).
3. Mitchell P: Turning the spotlight on cellular imaging. Nat. Biotechnol. 19, 1013-1017 (2001).
4. Michalet X, Pinaud F, Lacoste TD et al.: Properties of fluorescent semiconductor nanocrystals and their application to biological labeling. Single Mol 2 (4), 261-276 (2001).
5. Chan WCW, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S: Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol. 13, 40-46 (2002).
6. Wu X, Liu H, Liu J et al.: Immunofluorescent labeling of cancer marker Her2 and other cellular target with semiconductor quantum dots. Nat. Biotechnol. 21, 41-46 (2003).
7. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM: Long-term multiple color imaging of live cells using quantum dot bioconjugates: Nat. Biotechnol. 21, 47-51 (2003).
8. Gan X, Cui Y, Levenson RM, Chung LWK Nie S: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22(8), 969-976 (2004).
9. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS: Noninvasive imaging of quantum dots in mice. Bioconjugate Chem. 15(1), 79-86 (2004).
10. Michalet X, Pina ud FF, Bentolila LA et al.: Quantum dots for live cells, in vivo imaging and diagnostics. Science 307(5709), 538-544 (2005).
11. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H: Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4(6), 435-446 (2005).
12. Vashist SK, Tewari R, Bajpai PP, Bharadwaj LM, Raiteri R: Review of quantum dot technologies for cancer detection and treatment. J. Nanotechnol. 2, 1-14 (2006).
13. Rhyner MN, Smith AM, Gao X, Mao H, Yang L, Nie S: Quantum dots and multifunctional nanoparticles: new contras agents for tumor imaging. Nanomedicine 1(2), 1-9 (2006).
14. Stechell CH: Magnetic separations in biotechnology - a review. J. Chem. Technol. Bioiechnol. 35 (B), 175-182 (1985).
15. Olsvik O, Popovic T, Skjerve E et al.: Magnetic separation techniques in diagnostic microbiology. Clin. Microbiol. Rev. 7 (1), 43-54 (1994).
16. Pankhurst QA, Connolly J, Jones SK, Dobson J: Applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 36(13), R167 R181 (2003).
17. Ito A, Shinkai M, Honda H, Kobayashi T: Medical application of functionalized magnetic nanoparticles. J. Biosci. Bioeng. 100(1), 1-11 (2005).
18. Bonnemain B: Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. J. Drug Target 6 (3), 167-174 (1998).
19. Josephson L: Magnetic nanoparticles for MR imaging. BioMEMS Biomed Nanotechnol. 1, 227-237 (2006).
20. Alexiou C, Jurgons R, Seliger C, tro H: Medical applications of magnetic nanoparticles. J. Nanosci. Nanotechnol. 6(9/10). 2762-2768 (2006).
21. Duguet E, Vasseur S, Mornet S, Devoisselle JM: Magnetic nanoparticles and their applications in medicine. Nanomedicine1(2), 157-168 (2006).
22. Mornet S, Vasseur S, Grasset F et al.: Magnetic nanoparticle design for medical applications. Prog. Solid State Chem. 34(2-4), 237-247 (2006).
23. Berry CC, Curtis ASG: Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys. D Appl. Phys. 36, R198-R206 (2003).
24. Josephson L: Magnetic nanoparticles for MR imaging. In: BioMEMS and Biomedical Nanotechnology Volume I Biological and Biomedical hanotechnology. Ferrari M, Lee AP, Lee LJ. (Eris) Springer, NY, USA 227-237 (2006).
25. Häfeii UO, Chastellain M: Magnetic nanoparticles as drug carriers. In: Nanoparticulates as Drug Carriers. Torchilin VP (Ed.), Imperial College Press, London, UK, 397-418 (2006).
26. Duguet E, Vasseur S, Mornet S et al.: Towards a versatile platform based on magnetic nanoparticles for in vivo applications. Bull. Mater. Sci.. 29(6), 581-586 (2006).
27. Dobson J: Magnetic nanoparticles for drug delivery. Drug Del. Res.] 67(1), 55-60 (2006).
28. Jurgons R, Seliger C, Hilpert A, Trahms L, Odenbach S, Alexiou C: Drug loaded magnetic nanoparticles for cancer therapy. J Phys. Condens. Matter 18, S2893-S2902 (2006).
29. Hilger I, Hiergeist R, Hergt R, Winnefeld K, Schubert H, Kaiser WA: Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest. Radiol. 37(10), 580-586 (2002).
30. Shinkai M: Functional magnetic particles for medical application. J. Blosci. Bioeng. 94(6), 606-613 (2002).
31. Mornet S, Vasseur S, Grasset F, Duguet E: Magnetic nanoparticle design for medical diagnosis and therapy. J Mater. Chem. 14, 261-2175 (2004).
32. Häfeli UO: Magnetically modulated therapeutic systems. Inter. J Pharm. 277, 19-24 (2004).
33. Pradhan P. Giri J. amanta G et al.: Comparative evaluation of heating ability and biocompatibility of different ferrite-based magnetic fluids for hyperthermia application. J. Blomed. Mater. Res. Part B Appi. Biomater. 81(1), 12-22 (2006).
34. Kreuter J: Drug targeting with nanoparticles. Eur J Drug Metabol Pharm. 19(3), 253-256 (1994).
35. Kwon GS, Kataoka K: Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Del. Rev. 16(2), 295-309 (1995).
36. Langer R: Drug delivery and targeting. Nature 392 (Suppi. 6679), 5-10 (1998).
37. MuÈller RH, MagrEder K, Gohla S: Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 5 0, 161-177 (2000).
38. Pillai O, Panchagnula R: Polymers in drug delivery. Curc. Opin. Chem. Biol. 5(4), 447-451 (2001).
39. Sershen S, West J: Implantable, polymeric systems for modulated drug delivery. Adv. Drug Del. Rev. 54(9), 1225-1235 (2002).
40. Hillaireau H, Couvreur P: Polymeric nanoparticles as drug carriers. In: Polymers in drug delivery. Uchegbu IF (Ed.), CRC Press LLC, Boca Raton, FL, USA, 101-110 (2006).
41. Uchegbu IF: Pharmaceutical nanotechnology: polymeric vesicles for drug and gene delivery. Expert Opin. Drug Del. 3(5), 629-640 (2006).
42. Moghimi SMVE, Garcia ML, Al-Hanbali OAR, Rutt KJ: Polymeric nanoparticles as drug carriers and controlled release implant devices. In: Nanoparticulates as Drug Carriers. Torchilin VP (Ed.), Imperial College Press, London, UK, 29-42 (2006).
43. Shi Kam NW, O'Connell M. Wisdom JA, Dal H: Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl Acad Sci. USA 102(33), 11600-11605 (2005).
44. Bianco A, Kostarelos K, Partidos CD, Prato M: Biomedical applications of functionalized carbon nanotubes. Chem. Commun. 5, 571-577 (2005).
45. Bekyarova E, Ni Y, Malarkey EB et al.: Applications of carbon nanotubes in biotechnology and biomedicine. J Biomed Nanotechnol. 1(1), 3-17 (2005).
46. Lin Y, Taylor S, Li H et al.: Advances toward bioapplications of carbon nanotubes. J. Mater: Chem. 14(4), 527-541 (2004).
47. Link S, El-Sayed MA: Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J. Phys. Chem. B 103(40). 8410-8426 (1999).
48. Link S, El-Sayed MA: Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int. Rev. Phys. Chem. 19(3), 409-453 (2000).
49. El-Sayed MA: Some interesting properties of metals confined in time and nanometer space of different shapes. Acc. Chem. Res. 34(4), 257-264 (2001).
50. Link S, El-Sayed MA: Optical properties and ultrafast dynamics of metallic nanocrystais. Ann. Rev. Phys. Chem. 54, 331-366 (2003).
51. Masala O, Seshadri R: Synthesis routes for large volumes of nanoparticles. Annu. Rev. Mater. Res. 34, 41-81 (2004).
52. Hao E, Schatz G, Hupp J: Synthesis and optical properties of anisotropic metal nanoparticles. J. Fluor. 14(4), 331-341 (2004).
53. Daniel MC, Astruc, D: Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104, 293-346 (2004).
54. Hotter E, Fendier JH: Exploitation of localized surface plasmon resonance. Adv. mater. 16(19), 1685-1706 (2004).
55. Xia Y, Halas NJ: Shape-controtled synthesis and surface plasmonic properties of metallic nanostructures. MRS Bull 30, 338-348 (2005).
56. Murphy CJ, Sao TK, Cole AM et al.: Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J. Phys. Chem. B 109(29), 13857-13870 (2005).
57. P'erez-Juste J, Pastoriza-Santosa I, Luis M: Liz-Marz'an A, Mulvaney P: Gold nanorods: Synthesis, characterization and applications. Coord Chem. Rev. 249, 1870-1901 (2005).
58. Kelly KL, Coronado E, Zhao LL, Schatz GC: The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment. J. Phys. Chem. B 107(3), 668-677 (2003).
59. Hirsch LR, Stafford RJ, Bankson JA et al.: Nanoshell-mediated near infrared thermal therapy of tumors under MR guidance. Proc. Natl Acad. Sci. USA 100(23), 13549-13554 (2003).
60. Loo C H, Lin A, Hirsch LR et al.: Nanoshell-enabled photonics-based imaging and therapy of cancer: Technol. Cancer Res. Treat. 3, 33-40 (2004).
61. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL: Photo-thermal Tumor Ablation in mice using near infrared absorbing nanoshells. Cancer Lett. 209(2), 171-176 (2004).
62. Loo C, Lowery A, Halas NJ, West JL, Drezek R: Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 5(4), 709-711 (2005).
63. Chen J, Saeki F, Wiley BJ et al.: Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett. 5(3), 473-477 (2005).
64. Chen J, Wang D, Xi J et al.: Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett. 7(5), 1318-1322 (2007).
65. Turkevich J, Stvenson PC, Hillier J: A study of the nucleation and growth processes in the synthesis of colloidal gold. Disc. Farad. Soc. 11, 55-75 (1951).
66. Frens G: Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat. Phys. Sci. 241, 20-22 (1973).
67. Thaxton CS, Rosi NL, Mirkin CA: Optically and chemically encoded nanoparticle materials for DNA and pprotein detection. MRS Bull 30(5), 376-380 (2005).
68. Glomm WR: Functionalized gold nanoparticles for applications in bionnotechnology. J. Disp. Sci. Technol. 26(3), 389-414 (2005).
69. Paciotti GF, Kingston DG, Tamarkin L: Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Dev. Res. 67(1), 47-54 (2006).
70. Niidome Y, Niidome T. Surface modification of gold nanorods for bio-application. Jasco Report 48(2), 37-41 (2006).
71. Han G, Ghosh P, Rotello VM: Functionalized gold nanoparticles for drug delivery. Nanomedicine 2 (1), 113-123 (2007).
72. YU YY, Chang SS, Lee CL, Wang CRC: Gold nanorods: electrochemical synthesis and optical properties. J Phys. Chem. B 101(34), 6661-6664 (1997).
73. Jana NR, Gearheart L, Murphy CJ: Seed-mediated growth approach for shape-controlled synthesis of spheroidal and rod-like gold nanoparticles using a surfactant template. Adv. Mater. 13(18), 1389-1393 (2001).
74. Nikoobakht B, El-Sayed MA: Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method. Chem. Mater. 15(10), 1957-1962 (2003).
75. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD: Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1(3), 325-327 (2005).
76. Mie G: Contribution to the optics of turbid media, especially colloidal metal suspensions. Ann. Phys. 25, 377-445 (1908).
77. Papavassiliou CC: Optical properties of small inorganic and organic metal particles. Prog. Solid State Chem. 12, 185-271 (1979).
78. Bohren CF, Huffman DR: Absorption and scattering of light by small partides. Wiley, NY, USA (1983).
79. Kreibig U, Vollmer M: Optical Properties of Metal Clusters. Springer, Berlin, Germany. (1995).
80. Gans R: Form of ultramicroscopic particles of silver. Ann. Phys. 47, 270-284 (1915).
81. Link S, Mohamed MB, El-Sayed MA: Simulation of the optical absorption spectra of gold nanorods as a function of their aspect ratio and the effect of the medium dielectric constant. J. Phys. Chem. B 103(16), 3073-3077 (1999).
82. Link S. El-Sayed MA: Additions and corrections to simulation of the optical absorption spectra of gold nanorods as a function of their aspect ratio and the effect of the medium dielectric constant. J. Phys. N. Chem. B 109(20), 10531-10532 (2005).
83. Kerker M: The scattering of light and other electromagnetic radiation. Academic Press, NY, USA (1969).
84. Van De Huist HC: Light Scattering by Small Particles. Dover, NY, USA (1981).
85. Yguerabide J, Yguerabide EE: Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications. I. Theory. Anal. Biochem. 262, 137-156 (1998).
86. Yguerabide J, Yguerabide EE: Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications. II. Experimental characterization. Anal. Biochem. 262, 157-186 (1998).
87. Yguerabide J, Yguerabide EE: Resonance light scattering particles as ultrasensitive labels for detection of analytes in a wide range of applications. J. Cell. Biochem. Suppl. 37, 71-81 (2001).
88. Jin R, Cao Y, Mirkin CA, Kelly KL, Schatz GC, Zheng JC: Photoinduced conversion of silver nanospheres to nanoprisms. Science 294(5548), 1901-1903 (2001).
89. Sönnichsen C, Franzl T, Wilk T, Plessen GV, Feldmann J: Drastic reduction of plasmon damping in gold nanorods. Phys. Rev. Lett. 88(7), 077402-077406 (2002).
90. Raschke G, Kowarik S, Franzl T, Sonnichsen C, Klar TA, Feldmann J: Biomolecular recognition based on single gold nanoparticle light scattering. Nano Lett. 3(7), 935-938 (2003).
91. Orendorff CJ, Baxter SC, Goldsmith EC, Murphy CJ: Light scattering from gold nanorods: tacking material deformation. Nanotechnology 16(11), 2601-2605 (2005).
92. Asian K, Lakowicz, JR, Geddes CD: Nanogold plasmon resonance-based glucose sensing. 2. Wavelength-ratiometric resonance light scattering. Anal. Chem. 77(7), 2007-2014 (2005).
93. Orendorff CJ, Sau Tapan K, Murphy CJ Shape-dependent plasmon-resonant gold nanoparticies. Small 12(5), 636-639 (2006).
94. Zhu J, Huang L, Zhao J et al.: Shape dependent resonance light scattering properties of gold nanorods. Mater. Sci. Eng. B 121, 199-203 (2005).
95. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA: Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J. Phys. Chem. B 110(14), 7238-7248 (2006).
96. Lee KS, El-Sayed MA: Dependence of the enhanced optical scattering efficiency relative to that of absorption for gold metal nanorods on aspect ratio, size, end-cap shape, and medium refractive Index. J Phys. Chem. B 109(43), 20331-20338 (2005).
97. Sokolov K, Aaron J, Hsu B et al.: Optical systems for in vivo molecular imaging of cancer. Technol. Cancer Res. Treat. 2(6), 491-504 (2003).
98. Sokolov K, Follen M, Aaron J, Pavlova I, Malpica A, Lotan R, Richartz-Kortum R: Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res. 63, 1999-2004 (2003).
99. Raub CB, Orwin EJ, Haskell R Immunogold labeling to enhance contrast in optical coherence microscopy of tissue engineered corneal constructs. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2, 1210-1213 (2004).
100. El-Sayed IH, Huang X, El-Sayed MA: Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 5 (5), 829-834 (2005).
101. Huang X, El-Sayed IH, El-Sayed MA Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods: J. Am. Chem. Soc. 128(6), 2115-2120 (2006).
102. Aaron JS, Oh J, Larson TA. Kumar S, Milner TE, Sokolv KV: Increased optical contrast in imaging of epidermal growth factor receptor using magneticaly actuated hybrid gold/iron oxide nanoparticles. Optics Express 14 (26), 12930-12943 (2006).
103. Asian K, Lakowicz JR, Geddes CD: Plasmon light scattering in biology and medicine: new sensing approaches, visions and perspectives. Curr. Opin. Chem. Biol. 9, 538-544 (2005).
104. Taton TA, Lu G, Mirkin CA: Two-color labeling of oligonucleoticle arrays via size-selective scattering of nanoparticle probes. J. Am. Chem. Soc. 123, 5164-5165 (2001).
105. Zsigmondy RA: Colloids and the ultramicroscope-A manual of colloid chemistry and ultramicroscopy. John Wiley and Sons, Inc., NY, USA (1914).
106. Schultz S, Smith DR, Mock JJ, Schultz DA: Single-target molecule detection with nonbleaching multicolor optical immunolabels. Proc. Natl Acad. Sci. USA 97(3), 996-1001 (2000).
107. Bao P, Frutos AG, Greef C et al.: High-sensitivity detection of DNA hybridization on microarrays using resonance light scattering. Anal. Chem. 74(8), 1792-1797 (2002).
108. Schatz DA: Plasmon resonant particles for biological detection. Curr. Opin. 44, 13-22 (2003).
109. Mooradian A: Photoluminescence of metals. Phys. Rev. Lett. 22, 185-187 (1969).
110. Boyd GT, Yu ZH, Shen YR: Photoinnduced induced luminescennce from the nobel metals and its enhancement on roughened surfaces. Phys. Rev. B: Condens. Matter 33(12), 7923-7936 (1986).
111. Wilcoxon JP, Martin JE, Parsapour F, Wiedenman B, Kelley DF: Photoluminescence from nanosized gold clusters: J. Chem. Phys. 108(21), 9137-9143 (1998).
112. Link S, Beeby A, FitzGerald S, El-Sayed MA, Schaaff TG, Whetten RL: Visible to infrared luminescence from a 28-atom gold cluster. J. Phys. Chem. B 106(13), 3410-3415 (2002).
113. Zheng J, Zhang C, Dickson RM: Highly fluorescent,water-soluble, size-tunable gold quantum dots. Phys. Rev. Lett. 93(7), 077402.1-077402.4 (2004).
114. Mohamed MB, Volkov V, Link S, El-Sayed MA: The 'lightning' gold nanorods: fluorescence enhancement of over a million compared to the gold metal. Chem. Phys. Lett. 317 (6), 517-523 (2000).
115. Eustis S, El-Sayed MA: Aspect ratio dependence of the enhanced fluorescence intensity of gold nanorods: experimental and simulation study. J Phys. Chem. B 109(34), 16350-16356 (2005).
116. Li CZ, Male KB, Hrapovic S, Luong JHT: Fluorescence properties of gold nanorods and their application for DNA biosensing. Chem. Commun. 31, 3924-3926 (2005).
117. Bouhelier A, Beversluis MR, Novotny L: Characterization of nanoplasmonic structures by locally excited photoluminescence. Appl. Phys. Lett. 83 (24), 5041-5043 (2003).
118. Imura K, Nagahara T, Okamoto H: Plasmon mode imaging of single gold nanorods. J. Am. Chem. Soc. 126(40), 12730-12731 (2004).
119. Wang H, Huff TB, Zweifel DA et al.: In vitro and in vivo two-photon luminescence imaging of single gold nanorods. Proc. Natl Acad. Sci. USA 102(44), 15752-15756 (2005).
120. Durr NJ, Larson T. Smith DK, Korgei BA, Sokolov K, Ben-Yakar A: Two-photon luminescence imaging of cancer celts using molecularly targeted gold nanorods. Nano Lett. 7 (4). 941-945 (2007).
121. Shiohara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K: On the cyto-toxicity caused by quantum dots. Microbiol. Immunoz. 48(9), 669-675 (2004).
122. Fleischman M. Hendra PJ, Mcquillan AJ: Raman spectra of pyridine adsorbed at a silver electrode. Chem. Phys. Lett. 26(2), 163-166 (1974).
123. Jeanmaire DL, Van Duyne RP: Surface Raman spectroscopy. 1. Heterocyclic, antromatic, and alaphatic-amines adsorbed on anodized silver electrode. J. Electroanal. Chem. 84, 1-20 (1977).
124. Albercht M, Creighton JA: Anomalously intense Raman spectra of pyridine at a silver electrode. J. Am. Chem. Soc. 99, 5215-5217 (1977).
125. Persson BNJ: On the theory of surface-enhanced Raman scattering. Chem. Phys. Lett. 82 (3), 561-565 (1981).
126. Chang RK, Furtak TF: Surface enhanced Raman scattering. Plenum Press, NY, USA (1982)
127. Schatz GC: Theoretical studies of surface enhanced Raman scattering. Acc. Chem. Res. 17, 370-376 (1984).
128. Moskovits M: Surface enhanced spectroscopy. Rev. Mod. Phys. 57(3), 783-826 (1985).
129. Garrell RL: Surface-Enhanced Raman Spectroscopy. Anal. Chem. 61(6), 401A-411A (1989).
130. Chumanov GD, Efremov RG, Nabiev IR: Surface-enhanced Raman spectroscopy of biomolecules. I: Water-soluble proteins, dipeptides and amino acids J. Raman spectrosc. 21(1), 43-48 (1989).
131. Cotton TM, Kim JH, Chumanov GD: Application of surface-enhanced Raman spectroscopy to biological systems. J. Raman Spectrosc. 22(12), 729-742 (1991).
132. Otto A, Mrozek I, Grabhorn H, Akemann W: Surface-enhanced Raman scattering: J. Phys. Condens. Matter 4 (5), 1143-1212 (1992).
133. Garren RL. PJ, Cotton TM. Fundamentals and Applications of Surface Raman Spectroscopy. VCH Publishers Inc, FL, USA (1993).
134. Nablev I, Chourpa I, Manfait M: Applications of Raman and surface enhanced Raman scattering spectroscopy in medicine. J. Raman Spectrosc. 25, 13-23 (1994).
135. Campion A, Kambhampati, P: Surface-enhanced Raman scattering. Chem. Soc. Rev. 27, 241-250 (1998).
136. Kneipp K, Kneipp H, Itzkan I, Dasari RR, Feld MS: Surface-enhanced non-linear Raman scattering at the single-molecule level. Chem. Phys. 247, 155-162 (1999).
137. Tian ZQ, Ren R, Wu DY: Surface-enhanced Raman scattering: from noble to transition metals and from rough surfaces to ordered nanostructures. J. Phys. Chem. B 106(37), 9463-9483 (2002).
138. Kneipp K, Kneipp H, Itzkan I, Dasari RR, Feld MS: Surface-enhanced Raman scattering and biophysics. J. Phys. Condens Matter 14 (18), R597-R624 (2002).
139. Kneipp K, Moskovits M, Kneipp H: Surface-enhanced raman scattering: physics and applications. NY, USA Springer (2006).
140. Stuart DA, Haes AJ, Yonzon CR, Hicks EM, Van Duyne RP: Biological applications of localised surface plasmonic phenomenae. IEE Proc-Nanobiotechnol. 152(1), 13-32 (2005).
141. Haynes CL, Yonzon CR, Zhang X, Van Duyne RP: Surface-enhanced Raman sensors: early history and the development of sensors for quantitative biowarfare agent and glucose detection. J. Raman Spectrosc. 36, 471-484 (2005).
142. Manfait M, Morjani H, Minot JM, Debal V. Angiboust JF, Nabiev I: Drug target interactions on a single living cell. An approach by optical microspectroscopy. Proc. Soc. Photo Opt. Instrum. Eng. -Int Soc Opt Eng 1403, 695-707 (1991).
143. Nabiev IR, Morjani H, Manfait M: Selective analysis of antitumor drug interaction with living cancer cells as probed by surface-enhanced Raman spcctros copy. Eur. Biophys. J. 19(6), 311-316 (1991).
144. Manfait M, Nabiev I, Morjani H: Molecular events on single living cancer cells as studied by microspectrofluorometry and micro-SERS Raman spectroscopy. J. Cell Pharm. 3(1), 120125 (1992).
145. Morjani H, Riou JF, Nabiev I, Lavelle F. Manfait M: Molecular and cellular interactions between intoplicine, DNA, and topoisomerase II studied by surface-enhanced Raman scattering spectroscopy. Cancer Res. 53, 4784-4790 (1993).
146. Kneipp K, Haka AS, Kneipp H et al.: Surface-enhanced Raman spectroscopy in single living cells using gold nanoparticles. Appl. Spectrosc. 56(2), 150-154 (2002).
147. Kneipp J, Kneipp H, Rice WL, Kneipp K: Optical probes for biological applications based on Ssurface-enhanced Raman scattering from indocyanine green on gold nanoparticles. Anal. Chem. 77(8), 2381-2385 (2005).
148. Tang HW, Yang XB, Kirkham J, Smith DA: Probing Intrinsic and Extrinsic Components in Single Osteosarcoma Cells by Near-Infrared Surface-Enhanced Raman Scattering. Anal. Chem. 79(10), 3646-3653 (2007).
149. Nabiev I, Chourpa I, Manfait M: comparative studies of antitumor DNA intercalating agents, aclacinomycin and saintopin, by means of surface-enhanced raman scattering spectroscopy. J. Phys. Chem. 98(4), 1344-1350 (1994).
150. Chourpa I, Morjani H, Riou JF, Manfait M: Intracellular molecular interactions of antitumor drug amsacrine (m-AMSA) as revealed by surface-enhanced Raman spectroscopy. FEBS Lett. 397(1), 61-64 (1996).
151. Beljebbar A, Morjani H, Angiboust JF, Sockalingum GD, Polissiou M, Manfait M: Molecular and cellular interaction of the differentiating antitumour agent dimethylcrocetin with nuclear retinoic acid receptor as studied by near-infrared and visible SERS spectroscopy. J. Raman Spectrosc. 28 (2-3), 159-163 (1997).
152. Allain LR, Vo-Dinh T: Surface-enhanced Raman scattering detection of the breast cancer susceptibility gene BRCA1 using a silver-coated microarray platform. Anal. Chim. Acta 469(1), 149-154 (2002).
153. Vo-Dinh T, Allain LR, Stokes DL: Cancer gene detection using surface-enhanced Raman scattering (SERS), J. Raman Spectrosc. 33, 511-516 (2002).
154. Culha M, Stokes D. Allain LR, Vo-Dinh T. Surface-enhanced Raman scattering substrate based on a self-assembled monolayer for use in gene diagnostics. Anal. Chem. 75(22), 6196-6201 (2003).
155. Hawi SR, Rochanakij S, Adar F, Campbell WB, Nithipatikom K: Detection of membrane-bound enzymes in cells using immunoassay and Raman microspectroscopy. Anal. Biochem. 259(2), 212-217 (1998).
156. Seballos L, Zhang JZ, Sutphen R: Surface-enhanced Raman scattering detection of lysophosphaticlic acid. Anal. Bioanal. Chem. 383(5), 763-767 (2005).
157. Ansari DO, Stuart DA, Nie S: Surface-enhanced Raman spectroscopic detection of cancer biomarkers in intact cellular specimens: Proc. Soc. Photo Opt. Instrum. Eng. - Inter. Soc. Opt. Eng. 5699 82-90 (2005).
158. Kim JH, Kim JS, Choi H et al.: Nanoparticle probes with surface enhanced Raman spectroscopic tags for cellular cancer targeting. Anal. Chem. 78(19), 6967-6973 (2006).
159. Lee S, Kim S, Choo J et al.: Biological imaging of HEK293 cells expressing PLCç1 using surface-enhanced Raman microscopy. Anal. Chem. 79(3), 916-922 (2007).
160. Schlücker S, Küstner B, Punge A, Bonfig R, Marx A, Ströbel P: Immuno-Raman microspectroscopy: In situ detection of antigens in tissue specimens by surface-enhanced Raman scattering. J. Raman Spearosc. 37, 719-721 (2006).
161. Huang X, El-Sayed IH, Qian W, El-Sayed MA: Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp and polarized surface raman spectra: a potential cancer diagnostic marker. Nano Lett. 7(6), 1591-1597 (2007).
162. Kooij ES, Poelsema B: Shape and size effects in the optical properties of metallic nanorods. Phys. Chem. Chem. Phys. 8, 3349-3357(2006).
163. Du H, Fuh RA, Li J, Corkan A, Lindsey JS: PhotochemCAD††: A computer-aided design and research tool in photochemistry: Photochem. Pbotobiol. 68 (2). 141-142 (1998).
164. Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP: Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys. J. 84(6), 4023-4032 (2003).
165. Zharov VP, Gatitovsky V, Viegas M: Photothermal detection of local thermal effects during selective nanophotothermolysis. Appl. Phys. Lett. 83(24), 4897-4899 (2003).
166. Zharov VP, Galitovskaya E, Viegas M: Photothermal guidance for selective photothermolysis with nanoparticles. Proc. Soc. Photo Opt. Instrum. Eng. 5319, 291-300 (2004).
167. Zharov VP, Galitovskaya EN, Johnson C, Kelly T: Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: potential for cancer therapy. Lasers Surg. Med. 37, 219-226 (2005).
168. El-Sayed IH, Huang X, El-Sayed MA: Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett. 239(1), 129-135 (2006).
169. Huang X, Jain PK, El-Sayed IH, EI-Sayed MA: Determination of the minimum temperature required for selective photothermal destruction of cancer cells using immunotargeted gold nanoparticles. Photochem. Photobiol. 82(2), 412-417 (2006).
170. Takahashi H, Niidome T, Narial A, Niidome Y, Yamada S: Gold nanorod-sensitized cell death: microscopic observation of single living cells irradiated by pulsed near-infrared laser light in the presence of gold nanorods. Chem, Lett. 35(5), 500-501 (2006).
171. Huff TB, Tong L, Zhao Y, Hansen MN, Cheng JX, Wei A: Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine 2(1), 125-132 (2007).